Importantly, in a study that tested a higher dose of IL-2 combined with rapamycin, an increased and persistent ability of IL-2 to induce STAT5 phosphorylation, a defect found in endogenous Tregs isolated from patients with T1D, was observed (49). This evidence concerns the gene IL2 and type 1 diabetes mellitus.